Bodyweight gain under pregabalin therapy in epilepsy: Mitigation by counseling patients?

Seizure

Volumn 17, Issue 4, 2008, Pages 327-332

  Hoppe, Christian ^a   Rademacher, Michael ^a   Hoffmann, Judith M ^a   Schmidt, Dieter ^b   Elger, Christian E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Epilepsy Research Group   (Germany)

Author keywords

Adverse effects; Bodyweight gain; Epilepsy; Patient counseling; Pregabalin

Indexed keywords

PREGABALIN;

ADD ON THERAPY; ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR CONTROL; BODY WEIGHT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE TITRATION; DRUG TOLERABILITY; ENERGY EXPENDITURE; EPILEPSY; EVALUATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; BODY MASS INDEX; COUNSELING; DIET; EPILEPSY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; QUESTIONNAIRES; RISK; SEIZURES; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 42949169541     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.10.004     Document Type: Article

References (9)

1. Ness-Abramof R., and Apovian C.M. Drug-induced weight gain. Timely topics in medicine. Cardiovas Dis 9 (2005) E31
2. Jallon P., and Picard E. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf 24 (2001) 969-978
3. Gidal B.E., Sheth R.D., Magnus L., and Herbeuval A.F. Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials. Epilepsy Res 56 (2003) 121-126
4. Hamandi K., and Sander J.W. Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 15 (2006) 73-78
5. Frampton J.E., and Foster R.H. Pregabalin: in the treatment of generalised anxiety disorder. CNS Drugs 20 (2006) 685-693
6. Vartanian M.G., Radulovic L.L., Kinsora J.J., Serpa K.A., Vergnes M., Bertram E., et al. Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 68 (2006) 189-205
7. Ryvlin P. Defining success in clinical trials: profiling pregabalin, the newest AED. Eur J Neurol 12 Suppl 4 (2005) 12-21
8. Baker G.A., Jacoby A., Buck D., Stalgis C., and Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 38 (1997) 353-362
9. Freynhagen R., Strojek K., Griesing T., Whalen E., and Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263